# Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.

> **NCT00255307** · PHASE2 · COMPLETED · sponsor: **CV Technologies** · enrollment: 75 (actual)

## Conditions studied

- Upper Respiratory Infection

## Interventions

- **DRUG:** CVT-E002 ginseng extract

## Key facts

- **NCT ID:** NCT00255307
- **Lead sponsor:** CV Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2007-06-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255307, "Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00255307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*